These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 16273697)

  • 1. AIDS and the blood supply: an analysis of law, regulation, and public policy.
    Salbu SR
    Wash Univ Law Q; 1996; 74(4):913-80. PubMed ID: 16273697
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion-related AIDS litigation: permitting limited discovery from blood donors in single donor cases.
    Kunin PB
    Cornell Law Rev; 1991 May; 76(4):927-61. PubMed ID: 10111164
    [No Abstract]   [Full Text] [Related]  

  • 3. The nation's changing blood supply system.
    McCullough J
    JAMA; 1993 May; 269(17):2239-45. PubMed ID: 8474203
    [No Abstract]   [Full Text] [Related]  

  • 4. Transposition of the Blood Directive into national law--the perspective of Portugal.
    Gonçalves MH; Muon MC; Gonçalves Jd
    Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood money.
    Hunter M
    Discover; 1993 Aug; 14(8):70-8. PubMed ID: 11654912
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of HIV infection by transfusion: comparative analysis of systems adopted in developed countries.
    Reviron D; Auquier P; Manuel C; Enel P; Larher MP; Charrel J
    AIDS Public Policy J; 1991; 6(1):25-7. PubMed ID: 11651154
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of the blood supply. Liability for transfusion-associated AIDS.
    Janowitz WR
    J Leg Med; 1988 Dec; 9(4):611-22. PubMed ID: 3244008
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk management in transfusion medicine. The AIDS era underscores the need for a unified, comprehensive risk management program for all aspects of transfusion--from donor selection to post-transfusion outcomes.
    Berte LM; Dechristopher PJ
    MLO Med Lab Obs; 1996 Mar; 28(3):28-34. PubMed ID: 10156309
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient safety or profit: what incentives are blood shield laws and FDA regulations creating for the tissue banking industry?
    Williams JL
    Indiana Health Law Rev; 2005; 2(1):295-328. PubMed ID: 17111505
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood bank association not liable for tainted transfusion.
    AIDS Policy Law; 2000 Jan; 15(1):9. PubMed ID: 11367227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 May; 80(99):29841-906. PubMed ID: 26003966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS: the life and death conflict between the confidentiality of blood donors and the recovery of blood recipients.
    Fisher AL
    Wash Univ J Urban Contemp Law; 1992; 42():283-309. PubMed ID: 11659638
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood, AIDS, and bureaucracy: the crisis and the tragedy.
    Schmidt PJ
    Transfus Med Rev; 2011 Oct; 25(4):335-43. PubMed ID: 21632205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital and blood bank liability to patients who contract AIDS through blood transfusions.
    Greif RC
    Spec Law Dig Health Care (Mon); 1987 Dec; 9(6):7-28. PubMed ID: 10285120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How FDA safeguards the blood supply.
    Stone BW
    FDA Consum; 1991 Jun; 25(5):12-5. PubMed ID: 10111728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legal and regulatory problems facing blood suppliers.
    Sazama K
    Healthspan; 1989 Sep; 6(8):8-14. PubMed ID: 10295543
    [No Abstract]   [Full Text] [Related]  

  • 17. Is the gift still good? Examining the politics and regulation of blood safety in the European Union.
    Farrell AM
    Med Law Rev; 2006; 14(2):155-79. PubMed ID: 16831820
    [No Abstract]   [Full Text] [Related]  

  • 18. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US licenses blood test for AIDS.
    Joyce C; Anderson I
    New Sci; 1985 Mar; 105(1446):3-4. PubMed ID: 11655676
    [No Abstract]   [Full Text] [Related]  

  • 20. Transposing the E. E. U. Blood Directive into national law. Perspective of Slovenia.
    Potocnik M
    Transfus Clin Biol; 2005 Feb; 12(1):21-4. PubMed ID: 15814288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.